Literature DB >> 21084379

Expression and regulation of corticotropin-releasing factor receptor type 2β in developing and mature mouse skeletal muscle.

Yael Kuperman1, Orna Issler, Joan Vaughan, Louise Bilezikjian, Wylie Vale, Alon Chen.   

Abstract

Corticotropin-releasing factor receptor type 2 (CRFR2) is highly expressed in skeletal muscle (SM) tissue where it is suggested to inhibit interactions between insulin signaling pathway components affecting whole-body glucose homeostasis. However, little is known about factors regulating SM CRFR2 expression. Here, we demonstrate the exclusive expression of CRFR2, and not CRFR1, in mature SM tissue using RT-PCR and ribonuclease protection assays and report a differential expression of CRF receptors during C2C12 myogenic differentiation. Whereas C2C12 myoblasts exclusively express CRFR1, the C2C12 myotubes solely express CRFR2. Using cAMP luciferase assays and calcium mobilization measurements, we further demonstrate the functionality of these differentially expressed receptors. Using luciferase reporter assays we show a differential activation of CRFR promoters during myogenic differentiation. Transfections with different fragments of the 5'-flanking region of the mCRFR2β gene fused to a luciferase reporter gene show a promoter-dependent expression of the reporter gene and reveal the importance of the myocyte enhancer factor 2 consensus sequence located at the 3'-proximal region of CRFR2β promoter. Furthermore, we demonstrate that CRFR2 gene transcription in the mature mouse is stimulated by both high-fat diet and chronic variable stress conditions. Performing a whole-genome expression microarray analysis of SM tissues obtained from CRFR2-null mice or wild-type littermates revealed a robust reduction in retinol-binding protein 4 expression levels, an adipokine whose serum levels are elevated in insulin-resistant states. In correlation with the SM CRFR2β levels, the SM retinol-binding protein 4 levels were also elevated in mice subjected to high-fat diet and chronic variable stress conditions. The current findings further position the SM CRFR2 pathways as a relevant physiological system that may affect the known reciprocal relationship between psychological and physiological challenges and the metabolic syndrome.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21084379      PMCID: PMC3388898          DOI: 10.1210/me.2010-0308

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  67 in total

1.  IL-1alpha and TNFalpha down-regulate CRH receptor-2 mRNA expression in the mouse heart.

Authors:  S C Coste; K A Heldwein; S L Stevens; E Tobar-Dupres; M P Stenzel-Poore
Journal:  Endocrinology       Date:  2001-08       Impact factor: 4.736

2.  Type 2 corticotropin-releasing hormone receptor mRNA expression in the heart in hypertensive rats.

Authors:  S Makino; K Asaba; T Takao; K Hashimoto
Journal:  Life Sci       Date:  1998       Impact factor: 5.037

3.  Endotoxin regulates corticotropin-releasing hormone receptor 2 in heart and skeletal muscle.

Authors:  K A Heldwein; J E Duncan; P Stenzel; M B Rittenberg; M P Stenzel-Poore
Journal:  Mol Cell Endocrinol       Date:  1997-08-08       Impact factor: 4.102

4.  Differential regulation of the expression of corticotropin-releasing factor receptor type 2 (CRF2) in hypothalamus and amygdala of the immature rat by sensory input and food intake.

Authors:  M Eghbal-Ahmadi; S Avishai-Eliner; C G Hatalski; T Z Baram
Journal:  J Neurosci       Date:  1999-05-15       Impact factor: 6.167

5.  Mouse corticotropin-releasing factor receptor type 2alpha gene: isolation, distribution, pharmacological characterization and regulation by stress and glucocorticoids.

Authors:  Alon Chen; Marilyn Perrin; Bhawanjit Brar; Chien Li; Pauline Jamieson; Mike Digruccio; Kathy Lewis; Wylie Vale
Journal:  Mol Endocrinol       Date:  2004-10-28

6.  Decreased type 2 corticotropin-releasing hormone receptor mRNA expression in the ventromedial hypothalamus during repeated immobilization stress.

Authors:  S Makino; K Asaba; M Nishiyama; K Hashimoto
Journal:  Neuroendocrinology       Date:  1999-09       Impact factor: 4.914

7.  Effect of CRF and related peptides on calcium signaling in human and rodent melanoma cells.

Authors:  N Fazal; A Slominski; M A Choudhry; E T Wei; M M Sayeed
Journal:  FEBS Lett       Date:  1998-09-18       Impact factor: 4.124

8.  Altered expression of type 2 CRH receptor mRNA in the VMH by glucocorticoids and starvation.

Authors:  S Makino; M Nishiyama; K Asaba; P W Gold; K Hashimoto
Journal:  Am J Physiol       Date:  1998-10

9.  Human corticotropin-releasing hormone receptor: differences in subtype expression between pregnant and nonpregnant myometria.

Authors:  D Grammatopoulos; Y Dai; J Chen; E Karteris; N Papadopoulou; A J Easton; E W Hillhouse
Journal:  J Clin Endocrinol Metab       Date:  1998-07       Impact factor: 5.958

10.  Leptin effects on the expression of type-2 CRH receptor mRNA in the ventromedial hypothalamus in the rat.

Authors:  M Nishiyama; S Makino; K Asaba; K Hashimoto
Journal:  J Neuroendocrinol       Date:  1999-04       Impact factor: 3.627

View more
  9 in total

1.  CRF type 2 receptors mediate the metabolic effects of ghrelin in C2C12 cells.

Authors:  Eran Gershon; Wylie W Vale
Journal:  Obesity (Silver Spring)       Date:  2013-09-10       Impact factor: 5.002

2.  Involvement of mTOR in Type 2 CRF Receptor Inhibition of Insulin Signaling in Muscle Cells.

Authors:  Hongxia Chao; Haochen Li; Rebecca Grande; Vitor Lira; Zhen Yan; Thurl E Harris; Chien Li
Journal:  Mol Endocrinol       Date:  2015-04-15

3.  Susceptibility to PTSD-like behavior is mediated by corticotropin-releasing factor receptor type 2 levels in the bed nucleus of the stria terminalis.

Authors:  Maya Lebow; Adi Neufeld-Cohen; Yael Kuperman; Michael Tsoory; Shosh Gil; Alon Chen
Journal:  J Neurosci       Date:  2012-05-16       Impact factor: 6.167

4.  MicroRNA as repressors of stress-induced anxiety: the case of amygdalar miR-34.

Authors:  Sharon Haramati; Inbal Navon; Orna Issler; Gili Ezra-Nevo; Shosh Gil; Raaya Zwang; Eran Hornstein; Alon Chen
Journal:  J Neurosci       Date:  2011-10-05       Impact factor: 6.167

Review 5.  cAMP signaling in skeletal muscle adaptation: hypertrophy, metabolism, and regeneration.

Authors:  Rebecca Berdeaux; Randi Stewart
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-02-21       Impact factor: 4.310

6.  Retinol binding protein 4 abundance in plasma and tissues is related to body fat deposition in cattle.

Authors:  Yinuo Liu; Elke Albrecht; Dirk Dannenberger; Harald M Hammon; Christa Kuehn; Helga Sauerwein; Runjun Yang; Zhihui Zhao; Steffen Maak
Journal:  Sci Rep       Date:  2019-05-30       Impact factor: 4.379

7.  Ghrelin, via corticotropin-releasing factor receptors, reduces glucose uptake and increases lipid content in mouse myoblasts cells.

Authors:  Michal Elbaz; Eran Gershon
Journal:  Physiol Rep       Date:  2021-01

8.  Urocortin 2 promotes hypertrophy and enhances skeletal muscle function through cAMP and insulin/IGF-1 signaling pathways.

Authors:  Natalia Lautherbach; Dawit A P Gonçalves; Wilian A Silveira; Sílvia Paula-Gomes; Rafael Rossi Valentim; Neusa M Zanon; Marcelo G Pereira; Elen H Miyabara; Luiz C C Navegantes; Isis C Kettelhut
Journal:  Mol Metab       Date:  2022-04-04       Impact factor: 8.568

9.  Central urocortin 3 and type 2 corticotropin-releasing factor receptor in the regulation of energy homeostasis: critical involvement of the ventromedial hypothalamus.

Authors:  Peilin Chen; Christine Van Hover; Daniel Lindberg; Chien Li
Journal:  Front Endocrinol (Lausanne)       Date:  2013-01-07       Impact factor: 5.555

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.